Adage Capital Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120M | Buy |
|
|||||
|
2025
Q1 | $63.1M | Buy |
|
|||||
|
2024
Q4 | $63.2M | Buy |
|
|||||
|
2024
Q3 | $48.1M | Sell |
|
|||||
|
2024
Q2 | $49.9M | Buy |
|
|||||
|
2024
Q1 | $44.4M | Sell |
|
|||||
|
2023
Q4 | $115M | Sell |
|
|||||
|
2023
Q3 | $157M | Buy |
|
|||||
|
2023
Q2 | $124M | Buy |
|
|||||
|
2023
Q1 | $137M | Sell |
|
|||||
|
2022
Q4 | $231M | Sell |
|
|||||
|
2022
Q3 | $210M | Sell |
|
|||||
|
2022
Q2 | $285M | Sell |
|
|||||
|
2022
Q1 | $342M | Sell |
|
|||||
|
2021
Q4 | $439M | Buy |
|
|||||
|
2021
Q3 | $248M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $15.5M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $60.9M | Sell |
|
|||||
|
2020
Q1 | $213M | Buy |
|
|||||
|
2019
Q4 | $256M | Sell |
|
|||||
|
2019
Q3 | $235M | Sell |
|
|||||
|
2019
Q2 | $285M | Sell |
|
|||||
|
2019
Q1 | $325M | Sell |
|
|||||
|
2018
Q4 | $346M | Buy |
|
|||||
|
2018
Q3 | $327M | Buy |
|
|||||
|
2018
Q2 | $257M | Buy |
|
|||||
|
2018
Q1 | $237M | Sell |
|
|||||
|
2017
Q4 | $247M | Sell |
|
|||||
|
2017
Q3 | $248M | Sell |
|
|||||
|
2017
Q2 | $272M | Sell |
|
|||||
|
2017
Q1 | $286M | Buy |
|
|||||
|
2016
Q4 | $250M | Buy |
|
|||||
|
2016
Q3 | $233M | Buy |
|
|||||
|
2016
Q2 | $188M | Buy |
|
|||||
|
2016
Q1 | $108M | Sell |
|
|||||
|
2015
Q4 | $250M | Sell |
|
|||||
|
2015
Q3 | $283M | Buy |
|
|||||
|
2015
Q2 | $266M | Sell |
|
|||||
|
2015
Q1 | $314M | Buy |
|
|||||
|
2014
Q4 | $263M | Buy |
|
|||||
|
2014
Q3 | $234M | Sell |
|
|||||
|
2014
Q2 | $237M | Buy |
|
|||||
|
2014
Q1 | $249M | Buy |
|
|||||
|
2013
Q4 | $230M | Buy |
|
|||||
|
2013
Q3 | $183M | Sell |
|
|||||
|
2013
Q2 | $205M | Buy |
|